RxDoctor Payments Data

James Neill, MD

Family Medicine · Camdenton, MONPI 1013181601

Payments from drug & device makers

$481in general payments, 2019–2025

Across 26 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$91
  • Abbott$83
  • Collegium Pharmaceutical, Inc.$59
  • GSK$49
  • Pfizer$47
  • AstraZeneca$42
  • plus $110 from 6 others

What the payments were for

  • Food & beverage$481100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$481 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$1,905
Medicare patients
15
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban145$128,461
FarxigaDapagliflozin Propanediol87$82,013
OzempicSemaglutide50$48,316
XareltoRivaroxaban29$44,144
JardianceEmpagliflozin14$25,955
MounjaroTirzepatide21$25,043
JanuviaSitagliptin Phosphate31$24,465
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$18,649
JanumetSitagliptin Phos/Metformin Hcl11$16,508
Lantus SolostarInsulin Glargine,hum.Rec.Anlog58$15,205
EntrestoSacubitril/Valsartan17$14,092
Repatha SureclickEvolocumab23$14,091
Fluticasone-SalmeterolFluticasone Propion/Salmeterol88$13,083
Victoza 3-PakLiraglutide15$11,898
SymbicortBudesonide/Formoterol Fumarate42$11,545

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo, Paxlovid$47$140,212187 claims
AstraZenecaFarxiga, Symbicort$42$93,558129 claims
Boehringer IngelheimJardiance$16$25,95514 claims
Lilly USA, LLCMounjaro$17$25,04321 claims
GSKTrelegy Ellipta$49$18,64922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Camdenton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →